193 related articles for article (PubMed ID: 12461027)
1. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
[TBL] [Abstract][Full Text] [Related]
2. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
[TBL] [Abstract][Full Text] [Related]
3. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Simitsopoulou M; Roilides E; Maloukou A; Gil-Lamaignere C; Walsh TJ
Mycoses; 2008 Mar; 51(2):147-54. PubMed ID: 18254752
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.
Vikelouda K; Simitsopoulou M; Antachopoulos C; Skoura L; Roilides E
J Antimicrob Chemother; 2023 Apr; 78(4):1076-1083. PubMed ID: 36848199
[TBL] [Abstract][Full Text] [Related]
5. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.
Gil-Lamaignere C; Roilides E; Lyman CA; Simitsopoulou M; Stergiopoulou T; Maloukou A; Walsh TJ
Infect Immun; 2003 Nov; 71(11):6472-8. PubMed ID: 14573669
[TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Lewis RE; Wiederhold NP; Klepser ME
Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
Yustes C; Guarro J
Antimicrob Agents Chemother; 2005 Aug; 49(8):3498-500. PubMed ID: 16048969
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Panteliadis C; Walsh TJ; Roilides E
J Antimicrob Chemother; 2008 Apr; 61(4):810-7. PubMed ID: 18272514
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
Cuenca-Estrella M; Alastruey-Izquierdo A; Alcazar-Fuoli L; Bernal-Martinez L; Gomez-Lopez A; Buitrago MJ; Mellado E; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2008 Mar; 52(3):1136-9. PubMed ID: 18195067
[TBL] [Abstract][Full Text] [Related]
10. Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani.
Roilides E; Lyman CA; Armstrong D; Stergiopoulou T; Petraitiene R; Walsh TJ
Mycoses; 2006 Mar; 49(2):109-13. PubMed ID: 16466443
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
12. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.
Barbaric D; Shaw PJ
Med Pediatr Oncol; 2001 Aug; 37(2):122-5. PubMed ID: 11496350
[TBL] [Abstract][Full Text] [Related]
13. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
14. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.
Berenguer J; Rodríguez-Tudela JL; Richard C; Alvarez M; Sanz MA; Gaztelurrutia L; Ayats J; Martinez-Suarez JV
Medicine (Baltimore); 1997 Jul; 76(4):256-65. PubMed ID: 9279332
[TBL] [Abstract][Full Text] [Related]
15. Skin infection caused by Scedosporium apiospermum.
Karaarslan A; Arikan S; Karaarslan F; Cetin ES
Mycoses; 2003 Dec; 46(11-12):524-6. PubMed ID: 14641629
[TBL] [Abstract][Full Text] [Related]
16. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of
Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583
[No Abstract] [Full Text] [Related]
17. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.
Ortoneda M; Capilla J; Pujol I; Pastor FJ; Mayayo E; Fernández-Ballart J; Guarro J
J Antimicrob Chemother; 2002 Mar; 49(3):525-9. PubMed ID: 11864953
[TBL] [Abstract][Full Text] [Related]
18. [Scedosporium apiospermum disseminated infection in a single lung transplant recipient].
Solé A
Rev Iberoam Micol; 2011; 28(3):139-42. PubMed ID: 21700235
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.
Meletiadis J; Meis JF; Mouton JW; Rodriquez-Tudela JL; Donnelly JP; Verweij PE;
Antimicrob Agents Chemother; 2002 Jan; 46(1):62-8. PubMed ID: 11751112
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.
Afeltra J; Dannaoui E; Meis JF; Rodriguez-Tudela JL; Verweij PE
Antimicrob Agents Chemother; 2002 Oct; 46(10):3323-6. PubMed ID: 12234872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]